Price of a box of pazopanib (Viant) and market reference in different regions

Pazopanib is a multi-target tyrosine kinase inhibitor mainly used to treat patients with advanced clear cell renal cell carcinoma and soft tissue sarcoma. The drug has been officially launched in the country and included in the medical insurance system. This means that eligible patients can enjoy medical insurance reimbursement when using pazopanib, reducing the financial burden of the drug. Specific reimbursement ratios and policies may vary from region to region, and patients should consult their local hospital or pharmacy for the latest information.

In the domestic market, the price of the original pazopanib drug is about more than 1,000 yuan per box, which is relatively controllable. Due to the stability of the original drug in terms of efficacy and quality, it is usually regarded as the first choice, especially for patients who are using it for the first time or who have high requirements for drug efficacy. At the same time, doctors will also choose drugs reasonably based on the patient's condition, length of treatment and economic conditions when prescribing.

In foreign markets, pazopanib is divided into two types: original drugs and generic drugs. Original drugs are more expensive, ranging from more than one thousand to several thousand yuan per box, while generic drugs are more affordable. For example, the price of the Indian and Bangladeshi versions of pazopanib is usually only a few hundred yuan, and the drug ingredients are basically the same as the original drug. This provides patients with limited economic conditions with a more cost-effective option, and at the same time, the efficacy can basically reach the level of the original drug.

When choosing pazopanib, patients should comprehensively consider the source, price, and medical insurance coverage of the drug. Domestic patients are recommended to give priority to purchasing drugs through regular hospital pharmacies to ensure drug quality and reimbursement; if purchasing generic drugs through overseas channels, they should confirm the manufacturer's qualifications and drug quality to avoid purchasing substandard products. At the same time, during use, liver function, blood pressure and blood routine should be reviewed regularly according to doctor's advice to ensure efficacy and medication safety.

Reference link:https://www.drugs.com